Literature DB >> 10903718

Redundant and opposing functions of two tyrosine kinases, Btk and Lyn, in mast cell activation.

Y Kawakami1, J Kitaura, A B Satterthwaite, R M Kato, K Asai, S E Hartman, M Maeda-Yamamoto, C A Lowell, D J Rawlings, O N Witte, T Kawakami.   

Abstract

Protein-tyrosine kinases play crucial roles in mast cell activation through the high-affinity IgE receptor (FcepsilonRI). In this study, we have made the following observations on growth properties and FcepsilonRI-mediated signal transduction of primary cultured mast cells from Btk-, Lyn-, and Btk/Lyn-deficient mice. First, Lyn deficiency partially reversed the survival effect of Btk deficiency. Second, FcepsilonRI-induced degranulation and leukotriene release were almost abrogated in Btk/Lyn doubly deficient mast cells while singly deficient cells exhibited normal responses. Tyrosine phosphorylation of cellular proteins including phospholipases C-gamma1 and C-gamma2 was reduced in Btk/Lyn-deficient mast cells. Accordingly, FcepsilonRI-induced elevation of intracellular Ca2+ concentrations and activation of protein kinase Cs were blunted in the doubly deficient cells. Third, in contrast, Btk and Lyn demonstrated opposing roles in cytokine secretion and mitogen-activated protein kinase activation. Lyn-deficient cells exhibited enhanced secretion of TNF-alpha and IL-2 apparently through the prolonged activation of extracellular signal-related kinases and c-Jun N-terminal kinase. Potentially accounting for this phenomenon and robust degranulation in Lyn-deficient cells, the activities of protein kinase Calpha and protein kinase CbetaII, low at basal levels, were enhanced in these cells. Fourth, cytokine secretion was severely reduced and c-Jun N-terminal kinase activation was completely abrogated in Btk/Lyn-deficient mast cells. The data together demonstrate that Btk and Lyn are involved in mast cell signaling pathways in distinctly different ways, emphasizing that multiple signal outcomes must be evaluated to fully understand the functional interactions of individual signaling components.

Entities:  

Mesh:

Substances:

Year:  2000        PMID: 10903718     DOI: 10.4049/jimmunol.165.3.1210

Source DB:  PubMed          Journal:  J Immunol        ISSN: 0022-1767            Impact factor:   5.422


  54 in total

Review 1.  Rethinking the role of Src family protein tyrosine kinases in the allergic response: new insights on the functional coupling of the high affinity IgE receptor.

Authors:  Yasuko Furumoto; Claudia Gonzalez-Espinosa; Gregorio Gomez; Martina Kovarova; Sandra Odom; Valentino Parravicini; John J Ryana; Juan Rivera
Journal:  Immunol Res       Date:  2004       Impact factor: 2.829

2.  The limited contribution of Fyn and Gab2 to the high affinity IgE receptor signaling in mast cells.

Authors:  Emilia Alina Barbu; Juan Zhang; Reuben P Siraganian
Journal:  J Biol Chem       Date:  2010-03-24       Impact factor: 5.157

3.  Loss of TRPC1-mediated Ca2+ influx contributes to impaired degranulation in Fyn-deficient mouse bone marrow-derived mast cells.

Authors:  Ryo Suzuki; Xibao Liu; Ana Olivera; Lizath Aguiniga; Yumi Yamashita; Ulrich Blank; Indu Ambudkar; Juan Rivera
Journal:  J Leukoc Biol       Date:  2010-06-22       Impact factor: 4.962

4.  Nicotine inhibits Fc epsilon RI-induced cysteinyl leukotrienes and cytokine production without affecting mast cell degranulation through alpha 7/alpha 9/alpha 10-nicotinic receptors.

Authors:  Neerad C Mishra; Jules Rir-sima-ah; R Thomas Boyd; Shashi P Singh; Sravanthi Gundavarapu; Raymond J Langley; Seddigheh Razani-Boroujerdi; Mohan L Sopori
Journal:  J Immunol       Date:  2010-05-26       Impact factor: 5.422

5.  Positive and negative regulation of mast cell activation by Lyn via the FcepsilonRI.

Authors:  Wenbin Xiao; Hajime Nishimoto; Hong Hong; Jiro Kitaura; Satoshi Nunomura; Mari Maeda-Yamamoto; Yuko Kawakami; Clifford A Lowell; Chisei Ra; Toshiaki Kawakami
Journal:  J Immunol       Date:  2005-11-15       Impact factor: 5.422

6.  Deficiency of Src family kinases compromises the repopulating ability of hematopoietic stem cells.

Authors:  Christie M Orschell; Jovencio Borneo; Veerendra Munugalavadla; Peilin Ma; Emily Sims; Baskar Ramdas; Mervin C Yoder; Reuben Kapur
Journal:  Exp Hematol       Date:  2008-03-17       Impact factor: 3.084

7.  The Vibrio cholerae cytolysin promotes activation of mast cell (T helper 2) cytokine production.

Authors:  Diletta Arcidiacono; Sandra Odom; Barbara Frossi; Juan Rivera; Silvia R Paccani; Cosima T Baldari; Carlo Pucillo; Cesare Montecucco; Marina de Bernard
Journal:  Cell Microbiol       Date:  2007-11-15       Impact factor: 3.715

8.  A phase II trial of dasatinib in patients with metastatic castration-resistant prostate cancer treated previously with chemotherapy.

Authors:  Przemyslaw W Twardowski; Jan H Beumer; C S Chen; Andrew S Kraft; Gurkamal S Chatta; Masato Mitsuhashi; Wei Ye; Susan M Christner; Michael B Lilly
Journal:  Anticancer Drugs       Date:  2013-08       Impact factor: 2.248

Review 9.  The tyrosine kinase network regulating mast cell activation.

Authors:  Alasdair M Gilfillan; Juan Rivera
Journal:  Immunol Rev       Date:  2009-03       Impact factor: 12.988

Review 10.  Adapters in the organization of mast cell signaling.

Authors:  Damiana Alvarez-Errico; Eva Lessmann; Juan Rivera
Journal:  Immunol Rev       Date:  2009-11       Impact factor: 12.988

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.